FK-366 (zenarestat) is a potent aldose reductase inhibitor that prevents sorbitol accumulation in diabetic tissues, helping delay complications like neuropathy and cataracts. It has shown strong efficacy in animal models and early human trials, with oral dosing significantly reducing aldose reductase activity and serum uric acid levels. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Fk 366 and Zenarestatum. Its PubChem CID is 5724.
Zenarestat
| CAS No | 112733-06-9 |
|---|---|
| Molecular Formula | C17H11BrClFN2O4 |
| Molecular Weight | 441.60 g/mol |
| Synonyms | 2-[3-[(4-bromo-2-fluorophenyl)methyl]-7-chloro-2,4-dioxoquinazolin-1-yl]acetic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
FK-366 (zenarestat) is a potent aldose reductase inhibitor that prevents sorbitol accumulation in diabetic tissues, helping delay complications like neuropathy and cataracts.
The listed CAS number is 112733-06-9.
The listed molecular formula is C17H11BrClFN2O4.
The listed molecular weight is 441.60 g/mol.
2-[3-[(4-bromo-2-fluorophenyl)methyl]-7-chloro-2,4-dioxoquinazolin-1-yl]acetic acid.
The source lists Fk 366 and Zenarestatum.